• Radiotherapy, PD-1/TIGIT Blockade, and CD8+ Memory

  2026-09-12

  The 2025 Cancer Letters study shows that radiotherapy combined with PD-1 and TIGIT blockade can produce local tumor control, abscopal responses, and durable immune memory in multiple mouse models. Its central mechanistic contribution is the identification of activated CD8+ T cells and M1 macrophage–T-cell communication as key components of this therapeutic synergy.

• Amplex Red for H2O2 and ROS Assays

  2026-09-11

  Amplex Red converts low-abundance hydrogen peroxide into a quantifiable resorufin fluorescence signal for enzyme, microsomal, mitochondrial, and cell-based workflows. Its most important optimization is matrix-aware control design, especially adding superoxide dismutase when NADPH or NADH is present.

• Streptavidin-Cy3 for Microrobot Assay Design

  2026-09-11

  Streptavidin-Cy3 provides a bright, biotin-specific readout for validating biohybrid microrobot localization, barrier penetration, and biomolecular payload distribution. This guide connects fluorescence assay design with the latest Euglena-based microrobot research while emphasizing controls, spectral planning, and workflow limitations.

• FK866 (APO866): Translational Logic for NAMPT

  2026-09-10

  A mechanistic and strategic guide to using FK866 (APO866) in NAD metabolism, hematologic cancer research, and translational assay design. The article connects NAMPT dependence, energy collapse, mitochondrial injury, and context-specific host biology while outlining practical validation priorities.

• Forskolin as a Precision cAMP Assay Tool

  2026-09-10

  Forskolin is a direct adenylate cyclase activator that can turn cAMP signaling into a controlled experimental variable. This article explains how to use it as a mechanistic assay anchor, including its relevance to trophoblast stress, ferroptosis, stem-cell models, and translational study design.

• 2',7'-Dichlorofluorescein diacetate for ROS Assays

  2026-09-09

  Use 2',7'-Dichlorofluorescein diacetate to quantify broad intracellular oxidative stress across microscopy, flow cytometry, and plate-based workflows. This guide also shows how to interpret the probe alongside redox-responsive nanocarrier studies without mistaking a general ROS signal for proof of one molecular species.

• Ciprofloxacin Hydrochloride: Single-Cell Strategy

  2026-09-09

  Ciprofloxacin hydrochloride is more than a reference fluoroquinolone antibiotic: its DNA-damaging activity, context-dependent combination behavior, and model-specific host effects make it a valuable translational research tool. This article connects single-cell evidence with assay design, clinical relevance, and strategic decision-making.

• ST3GAL1, Sialylation, and F. nucleatum in CRC

  2026-09-08

  The reference study identifies ST3GAL1-dependent sialylation as a host-cell determinant of Fusobacterium nucleatum adhesion to colorectal cancer cells. It further connects bacterial persistence and tumor-promoting activity with an H3K27ac/ANGPTL4 axis, linking surface glycan biology to intratumoral colonization.

• 2',7'-Dichlorofluorescein Diacetate for ROS

  2026-09-08

  2',7'-Dichlorofluorescein diacetate is a cell-permeable fluorogenic probe for intracellular ROS measurement and broad oxidative stress assays. Its fluorescent product reports aggregate oxidation rather than a single reactive species, so meaningful interpretation requires matched controls and orthogonal validation.

• Maternal Deltamethrin Exposure and p53-Linked Ferroptosis

  2026-09-07

  This study links maternal deltamethrin exposure with impaired hippocampal learning and memory in male offspring through p53-associated ferroptosis. Its combination of behavioral testing, neuronal staining, biochemical profiling, and pharmacological intervention provides a mechanistic framework for studying environmental neurotoxicity and calcium-homeostasis disruption.

• Batimastat (BB-94): Assay Design Guide

  2026-09-07

  A scenario-based guide to using Batimastat (BB-94), SKU A2577, in MMP inhibition, viability, tumor, and neuromuscular research. It connects biochemical potency, formulation, controls, and interpretation to practical laboratory decisions.

• 2',7'-Dichlorofluorescein Diacetate in Oncology

  2026-09-05

  A translational guide to using 2',7'-Dichlorofluorescein diacetate as a broad intracellular redox reporter in cancer biology and ROS-responsive nanomedicine, with practical assay guidance, interpretation limits, and strategic context from self-adaptive pancreatic cancer nanocarriers.

• 6-FAM SE Workflows for Durable Molecular Labeling

  2026-09-04

  6-FAM SE enables stable, amine-directed labeling of proteins, peptides, and amino-functionalized nucleic acids for sequencing, conjugation quality control, and nanoparticle tracking. This practical guide connects robust fluorescent chemistry with assay design inspired by a glutathione-responsive melanoma nanomedicine study.

• Ac-YVAD-CMK in Kupffer Cell Inflammation Assays

  2026-09-04

  Ac-YVAD-CMK provides a time-controlled way to test whether caspase-1 activity contributes to pyroptosis, cytokine release, and liver injury in Kupffer cell models. This workflow connects chemical pathway inhibition with the TMEM16F membrane-repair findings reported in Listeria monocytogenes research while emphasizing controls that distinguish reduced inflammation from impaired host defense.

• Jasplakinolide: Actin Polymerization Inducer

  2026-09-03

  Jasplakinolide is a membrane-permeable actin polymerization inducer that also stabilizes pre-existing F-actin. Its approximately 15 nM affinity in purified actin assays makes it a useful actin cytoskeleton research tool, while its fungicidal and antiproliferative activities require context-specific controls.

7789 records 1/520 page Next 12345 下5页 Last page